How to Get Orladeyo (Berotralstat) Covered by Blue Cross Blue Shield in Florida: Complete Appeals Guide with Forms and Timelines
Answer Box: Getting Orladeyo Covered by Florida Blue Cross Blue Shield
Orladeyo (berotralstat) requires prior authorization from Florida Blue Cross Blue Shield as a Tier 4 specialty drug with a $150 copay after deductible. To get coverage, you need: (1) confirmed HAE diagnosis with C1-INH testing, (2) documented attack frequency (≥2 severe attacks per month or equivalent), and (3) prior authorization submission through your prescriber via Florida Blue's portal. If denied, you have 180 days for internal appeal, then 4 months for external review through Florida DFS. Start by having your HAE specialist submit the PA request with complete lab work and attack history documentation.
First step today: Contact your prescribing physician to initiate the prior authorization process through Florida Blue's provider portal.
Table of Contents
- Understanding Florida Blue's Coverage Requirements
- Step-by-Step: Fastest Path to Approval
- Common Denial Reasons & How to Fix Them
- Appeals Playbook for Florida
- Medical Necessity Letter Requirements
- Costs and Patient Assistance Options
- When to Escalate to State Regulators
- FAQ: Most Common Questions
Understanding Florida Blue's Coverage Requirements
Florida Blue classifies Orladeyo as a Tier 4 specialty medication that requires prior authorization and must be dispensed through designated specialty pharmacies. Here's what you need to know:
Coverage at a Glance
| Requirement | Details | Where to Verify | Source |
|---|---|---|---|
| Prior Authorization | Required for all Orladeyo prescriptions | Provider portal or member services | Florida Blue PA Requirements |
| Formulary Tier | Tier 4 specialty drug | 2026 Medication Guide | Florida Blue Formulary |
| Copay Structure | $150 after $500 deductible | Plan-specific benefits | Member portal |
| Specialty Pharmacy | Required dispensing channel | Varies by plan (ValueScript, NetResults, etc.) | Specialty Pharmacy Info |
| Age Requirement | 12 years or older | FDA labeling | Orladeyo Prescribing Information |
| Step Therapy | May apply - confirm with plan | Plan documents | Provider portal |
Key Clinical Requirements
For Orladeyo coverage, Florida Blue requires documentation of:
- Confirmed HAE diagnosis with appropriate laboratory testing (C1-INH levels, C4 complement)
- Attack frequency demonstrating need for prophylaxis (typically ≥2 severe attacks per month)
- Specialist involvement (allergist, immunologist, or HAE expert)
- Prior therapy considerations if step therapy applies to your specific plan
Step-by-Step: Fastest Path to Approval
1. Confirm Your HAE Diagnosis
Who: Your HAE specialist or allergist
What: Complete diagnostic workup including C1-INH functional and antigenic levels, C4 complement
Timeline: Allow 1-2 weeks for lab results
Source: HAE Diagnostic Guidelines
2. Document Attack History
Who: You and your healthcare team
What: Detailed record of attack frequency, severity, anatomical locations, and impact on daily activities
Timeline: Ongoing documentation recommended
3. Submit Prior Authorization
Who: Your prescribing physician
What: Complete PA form through Florida Blue's provider portal with all supporting documentation
Timeline: Submit immediately after prescription written
Portal: Florida Blue Provider PA System
4. Track Your Request
Who: You or your clinic staff
What: Monitor PA status and respond to any requests for additional information
Timeline: Florida Blue typically responds within 72 hours to 30 days
5. Prepare for Potential Appeal
Who: Your healthcare team with your involvement
What: Gather comprehensive medical records, attack logs, and specialist letters
Timeline: Start preparation immediately if initial PA is denied
Common Denial Reasons & How to Fix Them
| Denial Reason | How to Overturn | Required Documentation |
|---|---|---|
| Insufficient attack frequency | Provide detailed attack log showing ≥2 severe episodes per month | Attack diary, emergency room visits, missed work/school days |
| Missing specialist involvement | Get referral to HAE specialist | Letter from allergist/immunologist confirming diagnosis |
| Incomplete diagnostic workup | Submit all required lab results | C1-INH functional/antigenic levels, C4 complement, genetic testing if applicable |
| Step therapy not completed | Document trials/failures of other HAE prophylaxis | Medical records showing inadequate response or intolerance to alternatives |
| Age restriction | Confirm patient is ≥12 years old | Birth certificate or medical records with date of birth |
Tip: The most common reason for Orladeyo denials is incomplete attack documentation. Keep a detailed log including dates, severity, anatomical locations, and functional impact.
Appeals Playbook for Florida
Internal Appeal Process
Timeline: 180 days from denial notice
Submission: Through Florida Blue's Medical and Pharmacy Drug PA Portal via Availity or CoverMyMeds
Required Documents:
- Original denial letter
- Complete medical records
- Laboratory results
- Prior treatment documentation
- Letter of medical necessity from prescriber
Contact: Florida Blue at 1-877-719-2583 for appeal requirements and forms
Peer-to-Peer Review Option
If your initial PA or appeal is denied, your prescribing physician can request a peer-to-peer review:
Phone: 1-877-719-2583
Scheduling: Within 1-3 business days of request
Preparation: Have medical file, FDA labeling, and necessity rationale ready
External Review Process
Eligibility: After exhausting internal appeals for medical necessity denials
Timeline: 4 months from final internal denial
Authority: Florida Department of Financial Services (DFS)
Contact: 1-877-693-5236 or online complaint system
Decision Timeline: 45 days standard, 72 hours for expedited urgent cases
Cost: Free to patients
Binding: Yes, on the insurer
Medical Necessity Letter Requirements
Clinician Corner: Essential Elements
Your prescribing physician's letter of medical necessity should include:
1. Patient Demographics & Diagnosis
- Patient age (must be ≥12 years)
- Confirmed HAE subtype with supporting lab values
- ICD-10 codes (D84.1 for hereditary angioedema)
2. Clinical History
- Detailed attack frequency and severity
- Previous HAE treatments tried and outcomes
- Contraindications to alternative therapies
- Emergency interventions required
3. Treatment Rationale
- Why Orladeyo is medically necessary for this patient
- Expected therapeutic outcomes
- Monitoring plan
4. Supporting Evidence
- FDA labeling information
- Relevant clinical guidelines
- Peer-reviewed literature supporting use
Note: Include specific attack dates, locations (laryngeal, facial, abdominal), and functional impact. Vague statements like "frequent attacks" are insufficient.
Costs and Patient Assistance Options
Manufacturer Support Programs
BioCryst Patient Access Program
- Copay assistance for eligible patients
- Free drug program for uninsured/underinsured
- Contact: Orladeyo Patient Support
Additional Resources
Foundation Assistance
- Patient Advocate Foundation: copay relief programs
- National Organization for Rare Disorders (NORD): patient assistance programs
- HealthWell Foundation: specialty drug assistance
Estimated Costs
- WAC Price: $44,484.33 per 28-day supply (2025)
- With Insurance: Varies by plan (typically $150 copay after deductible for Florida Blue)
When to Escalate to State Regulators
Contact the Florida Department of Financial Services if:
- Florida Blue violates appeal timelines
- You're not receiving required appeal rights
- Procedural errors occur in the review process
Florida DFS Consumer Helpline: 1-877-693-5236
Email: [email protected]
Online: myfloridacfo.com
The DFS cannot force payment decisions but can ensure proper procedures are followed and document patterns of bad faith.
From Our Advocates
"We've seen the strongest Orladeyo approvals when patients work closely with HAE specialists who understand insurance requirements. One patient's approval was initially denied for 'insufficient documentation,' but succeeded on appeal when their allergist provided a comprehensive letter detailing specific attack patterns, emergency room visits, and why oral prophylaxis was preferred over injectable alternatives. The key was translating clinical need into insurance language."
FAQ: Most Common Questions
How long does Florida Blue prior authorization take?
Standard PA decisions are made within 30 days, but many are processed within 72 hours. Expedited reviews for urgent cases are completed within 72 hours.
What if Orladeyo isn't on my Florida Blue formulary?
You can request a formulary exception through the Coverage Exception Request process. Your physician will need to provide medical justification for why formulary alternatives aren't appropriate.
Can I get expedited approval if I'm having frequent attacks?
Yes, if your physician certifies that delays would jeopardize your health, you can request expedited review at both the PA and appeal levels.
Does step therapy apply to Orladeyo in Florida?
Step therapy requirements vary by specific Florida Blue plan. Check your plan documents or ask your physician to verify requirements during the PA submission.
What if I've tried HAE treatments in another state?
Documentation from out-of-state providers counts toward step therapy requirements. Ensure your current physician has complete records of prior treatments and outcomes.
How do I find a HAE specialist in Florida?
The Hereditary Angioedema Association maintains a provider directory of HAE specialists by state.
About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating targeted, evidence-backed rebuttals. The platform analyzes denial letters and plan policies to draft point-by-point appeals aligned with each insurer's specific requirements, pulling the right clinical evidence and procedural details to maximize approval chances.
For complex denials like Orladeyo coverage, having expert support can make the difference between prolonged delays and timely access to needed therapy. Counterforce Health's system is designed specifically to navigate the intricate requirements of specialty drug approvals and appeals.
Sources & Further Reading
- Florida Blue Prior Authorization Requirements
- Florida Blue Medication Guide and Formulary
- Orladeyo Prescribing Information and Support
- Florida Department of Financial Services Insurance Appeals
- Hereditary Angioedema Association Treatment Guidelines
This guide is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and medical circumstances. Always consult with your healthcare provider and insurance plan for specific coverage questions. For additional help with insurance appeals in Florida, contact the Department of Financial Services Consumer Helpline at 1-877-693-5236.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.